Tianjin Ringpu Bio-Technology (SHE:300119) forecasts its attributable profit to grow 50% to 70% to between 244.2 million yuan and 276.7 million yuan in the first half from 162.8 million yuan in the year-ago period, according to a Monday filing with the Shenzhen bourse.
The foreseen increase is attributable to a steady market share increase in its poultry and livestock animal health sector, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments